SomnoMed Limited (SOMNF)
OTCMKTS · Delayed Price · Currency is USD
0.5149
+0.0524 (11.33%)
At close: Dec 31, 2025
SomnoMed Revenue
In the fiscal year ending June 30, 2025, SomnoMed had annual revenue of 111.49M AUD with 21.65% growth. SomnoMed had revenue of 57.78M in the half year ending June 30, 2025, with 32.36% growth.
Revenue
111.49M AUD
Revenue Growth
+21.65%
P/S Ratio
1.55
Revenue / Employee
371.64K AUD
Employees
300
Market Cap
113.11M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 111.49M | 19.84M | 21.65% |
| Jun 30, 2024 | 91.65M | 8.03M | 9.61% |
| Jun 30, 2023 | 83.62M | 11.04M | 15.20% |
| Jun 30, 2022 | 72.58M | 9.87M | 15.75% |
| Jun 30, 2021 | 62.71M | 5.41M | 9.44% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |